Tourniquets Type Combat Application Tourniquet: Proximal or Distal Location, Simple or Staggered on Upper and Lower Limb

Summary

A tourniquet is used to stop abundant bleeding when simple compression is not effective. The investigators will study the vascular suffering of the tourniquets according to their location on the limb: limb (arm / thigh) or distal (forearm / leg). Vascular suffering will be evaluated by the loss of the radial doppler flux for the tourniquets placed on the upper limb and in the tibial anterior to the lower limb by the loss of the pulse oximetry pulse and the collection of the signs described by the volunteers (pain, Paresthesia, cold sensation).

Conditions

• Hemorrhage

Interventions

DEVICE

Proximal single upper limb

Measurement of pain, pressure under tourniquet, feeling and abolition of pulse doppler and pulse oximetry

DEVICE

Proximal staggered upper limb

Measurement of pain, pressure under tourniquet, feeling and abolition of pulse doppler and pulse oximetry

DEVICE

Distal single upper limb

Measurement of pain, pressure under tourniquet, feeling and abolition of pulse doppler and pulse oximetry

DEVICE

Distal staggered upper limb

Measurement of pain, pressure under tourniquet, feeling and abolition of pulse doppler and pulse oximetry

DEVICE

Proximal single lower limb

Measurement of pain, pressure under tourniquet, feeling and abolition of pulse doppler and pulse oximetry

DEVICE

Proximal staggered lower limb

Measurement of pain, pressure under tourniquet, feeling and abolition of pulse doppler and pulse oximetry

DEVICE

Distal single lower limb

Measurement of pain, pressure under tourniquet, feeling and abolition of pulse doppler and pulse oximetry

DEVICE

Distal staggered lower limb

Measurement of pain, pressure under tourniquet, feeling and abolition of pulse doppler and pulse oximetry

Sponsors & Collaborators

• University Hospital, Brest

  lead OTHER

Principal Investigators

• Emilie Gelin, MD · CHU de Brest

Study Design

Allocation

NON_RANDOMIZED

Purpose

OTHER

Masking

NONE

Model

CROSSOVER

Eligibility

Min Age

18 Years

Sex

ALL

Healthy Volunteers

Yes

Timeline & Regulatory

Start

2017-07-31

Primary Completion

2017-10-23

Completion

2017-10-23

Countries

• France

Study Locations